Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

JC&C Interim Management Statement

27 Apr 2022 11:20

RNS Number : 5457J
Jardine Matheson Hldgs Ltd
27 April 2022
 

 

To: Business Editor 27th April 2022 For immediate releaseJardine Cycle & Carriage LimitedInterim Management Statement The following announcement was issued today by the Company's 75%-owned subsidiary, Jardine Cycle & Carriage Limited.For further information, please contact:Jardine Matheson LimitedJoey Ho (65) 9765 0717Brunswick Group LimitedBen Fry (65) 9017 988627th April 2022JARDINE CYCLE & CARRIAGE LIMITEDINTERIM MANAGEMENT STATEMENTJardine Cycle & Carriage ("JC&C" or "the Group") today issues its Interim Management Statement for the first quarter of 2022.JC&C delivered an improved performance in the first three months of 2022, compared to the same period last year, mainly due to higher contributions from Astra and Other Strategic Interests.Astra reported an 84% increase in earnings, driven primarily by the domestic economic recovery and higher commodity prices. Astra's increased car sales benefited from luxury sales tax incentives, and Astra's financial services division recorded higher lending volumes. The heavy equipment and mining division saw a strong performance, with increased heavy equipment sales and higher coal selling prices. In addition, Astra's agribusiness division recorded higher crude palm oil prices.Direct Motor Interests saw a relatively stable performance overall. Tunas Ridean delivered improved profits, reporting higher contributions from its automotive, financial services and vehicle rental operations. There was also improved performance by Cycle & Carriage Bintang in Malaysia, with the continuation of the government sales tax reduction and the implementation of cost control initiatives. Cycle & Carriage in Singapore, however, recorded lower sales under challenging trading conditions due to high COE prices and stock supply shortages.Other Strategic Interests continued to perform well, as THACO achieved higher automotive sales and margins mainly due to an improved sales mix, supported by a reduction in registration fees for locally-assembled vehicles. Siam City Cement, however, was affected by high energy costs and the devaluation of the Sri Lanka rupee.While the Group is encouraged by the good performance achieved in the first quarter, it remains cautious about the uncertainties arising from the pandemic and geopolitical tensions for the rest of the year.CORPORATE PROFILEJardine Cycle & Carriage is the investment holding company of the Jardine Matheson Group in Southeast Asia. JC&C seeks to grow with Southeast Asia by investing in market-leading businesses based on the themes of urbanisation and the emerging consumer class. The Group works closely with its businesses to enable them to achieve their potential and elevate their communities.The Group has a 50.1% interest in Astra, a diversified group in Indonesia, which is also the largest independent automotive group in Southeast Asia.JC&C also has significant interests in Vietnam, including 26.6% in THACO Corporation, 31.2% in Refrigeration Electrical Engineering Corporation and 10.6% in Vinamilk. Its 25.5%-owned Siam City Cement also has a presence in South Vietnam and operates in Thailand, Sri Lanka, Cambodia, and Bangladesh.The Direct Motor Interests in JC&C's portfolio are the Cycle & Carriage businesses in Singapore, Malaysia and Myanmar, and 46.2%-owned Tunas Ridean in Indonesia.JC&C is a leading Singapore-listed company, 75%-owned by the Jardine Matheson Group. Together with its subsidiaries and associates, JC&C employs around 240,000 people across Southeast Asia. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEWFSWEESEFL
Date   Source Headline
8th May 201912:32 pmRNSInterim Management Statement
2nd May 201910:20 amRNSDividend
29th Apr 201910:49 amRNSFirst Quarter 2019 Results of PT Hero
26th Apr 201910:35 amRNSJC&C 2019 First Quarter Financial Statements
24th Apr 201911:09 amRNSPT Astra 2019 First Quarter Financial Statements
18th Apr 201910:57 amRNSDividend
4th Apr 201910:11 amRNSAnnual Financial Report
29th Mar 20199:15 amRNSTotal Voting Rights
27th Mar 20199:12 amRNSCirc re. Scrip Dividend Scheme
26th Mar 20199:14 amRNSDirector/PDMR Shareholding
25th Mar 20199:12 amRNSBlock listing Interim Review
20th Mar 201910:53 amRNSDirector/PDMR Shareholding
7th Mar 20199:12 amRNSDirector/PDMR Shareholding
28th Feb 20199:25 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:23 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:19 amRNSFull Year 2018 Results of PT Hero
28th Feb 20199:18 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 Preliminary Announcement of Results
27th Feb 20199:50 amRNSJC&C 2018 Financial Statements
27th Feb 20199:41 amRNSPT Astra Intl TBK - 2018 FY Financial Statements
31st Jan 20199:07 amRNSTotal Voting Rights
30th Jan 20199:15 amRNSNotice of 2018 Final Results
24th Jan 201911:08 amRNSDirector/PDMR Shareholding
8th Jan 201910:18 amRNSDirector/PDMR Shareholding
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 201811:32 amRNSDirector Declaration
17th Dec 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
7th Dec 20189:08 amRNSDirectorate Change
30th Nov 20189:16 amRNSTotal Voting Rights
23rd Nov 20189:10 amRNSDF Completes Partnership with Robinsons in Phl
8th Nov 20189:20 amRNSInterim Management Statement
8th Nov 20189:17 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:10 amRNSInterim Management Statement
7th Nov 20189:21 amRNS2018 Third Quarter Financial Statements
31st Oct 20189:10 amRNSTotal Voting Rights
30th Oct 201810:02 amRNSNine Months 2018 Results of PT Hero
29th Oct 20187:00 amRNSPT Astra 2018 Third Quarter Financial Statements
24th Oct 201811:31 amRNSDirector/PDMR Shareholding
11th Oct 201811:52 amRNSDirector/PDMR Shareholding
10th Oct 201810:13 amRNSDirector/PDMR Shareholding
5th Oct 201810:35 amRNSAdditional Listing
2nd Oct 201811:04 amRNSForm 8.3 - Jardine Lloyd Thompson Group plc
2nd Oct 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.